维普期刊资源整合服务平台（V6.5）

38篇 您的检索式：作者名="Clark CM Jr"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine(HOE901) and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
2	Meningitis in preterm neonates: importance of cere- brospinal fluid parameters 显示文摘	Smith PB Garges HP Cotton CM Walsh TJ Clark RH Benja- min DK Jr	2008	Am J Perinatol2008，25，7：	1
3	Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
4	Basal insulintherapy in type 2 diabetes: 28 - week comparison of insulin glargine (HOEg01) and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
5	Basal insulin therapy in type 2 diabetes:28-week comparison of insulin glargine (HOE 901) and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
6	Basalin sulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE901) and NPH insulin 显示文摘	Rosenstock J Schwartz Sir Clark CM Jr	2001	Diabetes Care2001，24，4：	1
7	Basal insulin therapy in type 2 diabetes: 28 - week comparison of insulin glargin( HOE901 ) and NPH insulin 显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
8	Docetaxel:an active drug for squamous cell carcinoma of the head and neck显示文摘	Clark JR Norris CM	1996	J Clin Oncol1996，14，：	1
9	Docetaxel: an active drug for squamous cell carcinoma of the head and neck 显示文摘	Dreyfuss AI Clark JR Norris CM	1996	J Clin Oncol1996，14，5：	1
10	Basal insulin therapy in type 2 diabetes : 28 - week comparison of insulin glargine ( HOE 901 ) and NPH insulin显示文摘	ROSENSTOCK J SCHWARTZ S L CLARK CM Jr	2001	Diabetes Care2001，24，4：	1
11	Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901 ) AND npn Insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
12	Induction chemotherapy with cisplatin,fluorouracil,and high-dose leucovorin for squamous cell carcinoma of the head and neck:long-term results显示文摘	Busse PM Norris CM Jr	1997	J Clin Oncol1997，15，：	1
13	Basal insulin therapy in type 2 diabetes: 28-week comparison of insulin glargine (HOE 901 )AND NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Oiabetes Care2001，21，4：	1
14	Basal insulin therapy in type 2 diabetes: 28- week comparison of insuiin glargine (HOE901) and NPH insulin 显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
15	Basal insulin glargine in patients with type 1 diabetes:28-week comparison of insulin glag ine(HOE 901) and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
16	The National Diabetes Education Program, changing the way diabetes is treated:comprehensive care 显示文摘	Clark CM Jr Fradkin JE Hiss RG	2001	Diabetes Care2001，24，4：	1
17	Basal insulin therapyin type 2 diabetes:28-week comparision of insulin glargin(HOE901)and NPH insulin显示文摘	Rosentock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
18	Basal insulin therapy in type 2diabetes:28-week comparison of insulin glargine(HOE 901)and NPH insulin显示文摘	Rosenstock J Schwartz SL Clark CM Jr	2001	Diabetes Care2001，24，4：	1
19	Docetaxel: An active drug for squamous cell carcinoma of the head and neck 显示文摘	Dreyfuss AI Clark JR Norris CM		J Clin Oncol0，14，：	1
20	Type 2 diabetes and macro vascular disease1Epidemiology and etiology显示文摘	Clark CM Jr Perry RC	1999	Am Heart J1999，138，51：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示